A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

20042,691 citationsJournal Article

Authors

John P. Neoptolemos · University of Liverpool

Deborah Stocken · University of Birmingham

Helmut Friess · Heidelberg University

Claudio Bassi · University of Verona

Janet Dunn · University of Birmingham

Helen Hickey · University of Liverpool

Hans G. Beger ·

Abstract

Adjuvant chemotherapy has a significant survival benefit in patients with resected pancreatic cancer, whereas adjuvant chemoradiotherapy has a deleterious effect on survival.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Pancreatitis Pathology and Treatment Neuroendocrine Tumor Research Advances

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 350, Issue 12, pp. 1200-1210

DOI: 10.1056/nejmoa032295

Field-Weighted Citation Impact: 55.50